Skip to content

Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06181682
Enrollment
70
Registered
2023-12-26
Start date
2024-01-31
Completion date
2024-03-31
Last updated
2023-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

compare the effectiveness of intranasal dexmedetomidine and midazolam as a premedication in sedation of preschool children in GI endoscopy

Interventions

DRUGDexmedetomidine

Intranasal Dexmedetomidine

DRUGMidazolam

Intranasal midazolam

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Children of preschool age (2-6 years old). * American scocity of anaesthesiology (ASA) I - II children. * Expected duration of the procedure is less than 50 minutes.

Exclusion criteria

* Cardiac arrhythmia, congenital heart disease, or hemodynamic or respiratory instability; children at risk for airway obstruction. * Behavioral, mental or developmental abnormality (example: mental retardation, Attention Deficit Hyperactivity Disorder ADHD, Autism, Down syndrome). * Regular intake of either brain stimulant or depressive drugs (example: Methylphenidate, amphetamine-dextroamphetamine and diazepam respectively). * Parent's refusal. * Emergency case. * Allergy to any of the used drugs

Design outcomes

Primary

MeasureTime frameDescription
Sedation status at separation from the parentwithin 30 minutes after drugs administrationParental separation anxiety scale (PSAS) ,A score of 1-2 was considered satisfactory separation and a score of 3-4 was considered unsatisfactory separation.

Secondary

MeasureTime frameDescription
Onset of sedationwithin 30 minutes after drugs administrationOnset of sedation will be recorded according to Modified RAMSAY Sedation Scale when the score reaches 3 points, patient is then ready to be transferred.
awakening timewithin 15 minutes after end of anaesthesiarecovery time (defined as return of consciousness, recovery of protective air way reflexes and resumption of motor activity)
post-operative emergence delirium and agitation.within 30 minutes from recovery(PAED) scale: Pediatric Anesthesia Emergence Delirium (PAED) scales. scale from 0 to 20. higher scores mean a worse outcome

Contacts

Primary Contactmarwa Salem, MD
marwamostafa@med.asu.edu.eg1003591259

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026